20
significantly enhance our market reach
in the Northeast and Mid-Atlantic
states. See further discussion in
of the Notes to Condensed Consolidated Financial Statements included in this Quarterly Report.
Effective on
September 9,
2024, we
completed a
strategic investment
with Crepini
LLC, establishing
a new
egg products
and
prepared foods venture.
Crepini LLC, founded
in 2007, grew
its brand throughout
the United States
and Mexico featuring
egg
wraps, protein pancakes, crepes, and
wrap-ups, which are sold
online and in over 3,500
retail stores. The new entity,
located in
Hopewell Junction,
New York,
operates as
Crepini Foods
LLC (“Crepini”).
We
capitalized Crepini
with approximately
$6.75
million in cash to purchase additional equipment and other assets and fund working capital in exchange for a 51% interest in the
new venture. Crepini LLC contributed its existing assets and business in exchange for a 49% interest in the new venture.
In
fiscal
2022,
we
announced
a
strategic
investment
in
a
new
entity,
MeadowCreek
Food,
LLC
(“MeadowCreek”),
which
became
a
majority-owned
subsidiary.
During
March
2023,
MeadowCreek
began
operations
with
a
focus
on
being
a
leading
provider of
hard-cooked eggs.
During second
quarter 2025,
we acquired
the remaining
ownership interests
in MeadowCreek
and it became a wholly-owned subsidiary.
In
second
quarter
2024,
we
acquired
the
assets
of
Fassio
Egg
Farms,
Inc.
(“Fassio”)
related
to
its
commercial
shell
egg
production and processing business. Fassio
owned and operated commercial shell
egg production and processing facilities
with
a
capacity
at
the
time
of
acquisition
of
approximately
1.2
million
laying
hens,
primarily
cage-free,
a
feed
mill,
pullets,
a
fertilizer production and composting operation and land located in Erda, Utah, outside Salt Lake City. This acquisition provided
us with
an opportunity
to expand
our market
presence in
Utah and
the western
U.S., particularly
for cage-free
eggs. In
fourth
quarter 2024, we acquired a broiler processing plant, hatchery and feed mill in Dexter, Missouri for use in shell egg production.
HPAI
Outbreaks of HPAI have continued to occur in U.S. poultry flocks. In In
calendar 2024, 38.4 million commercial layer hens and
1.8 million pullets were depopulated due to HPAI. Approximately 13.6 million commercial layer hens and 500,000 pullets were
depopulated in December 2024 alone.
Our facilities in Kansas and Texas which experienced HPAI
in fiscal 2024 are now fully operational.
We
remain dedicated
to robust
biosecurity programs
across our
locations; however,
no farm
is immune
from HPAI.
HPAI
is
currently widespread in the
wild bird population worldwide.
According to the U.S.
Centers for Disease Control
and Prevention
(“CDC”), as of January 6, 2025, there were outbreaks in 917
herds of dairy cows in 16 states, and in 2024
there were 66 human
cases
in
the
U.S.,
almost
entirely
among
poultry
and
dairy
workers.
However,
in
2024,
one
of
the
human
cases
resulted
in
severe illness
after the
patient was
exposed to
sick and
dead birds
in backyard
flocks.
The patient,
who was
reported to
have
underlying health
conditions, died
in January
2025. There
have been
no reported
cases of
person-to-person spread.
According
to the CDC, the human health risk to the
U.S. public from the HPAI
virus is considered to be low.
The extent of possible future
outbreaks
among
U.S.
commercial
egg
layer
flocks,
with
heightened
risk
during
migration
seasons,
cannot
be
predicted.
According to the USDA, HPAI
cannot be transmitted through safely handled and properly cooked eggs. There is no known risk
related
to
HPAI
associated
with
eggs
that
are
currently
in
the
market
and
no
eggs
have
been
recalled.
For
additional
information, see
the 2024
Annual Report,
Part II
Item 7
“Management’s
Discussion and
Analysis of
Financial Condition
and
Results of Operations – HPAI.”
EXECUTIVE OVERVIEW
For the
second quarter
and first
two quarters
of fiscal
2025, we
recorded a
gross profit
of $356.0
million and
$603.3 million,
respectively,
compared to $91.1
million and $136.6
million, respectively,
for the same
periods of fiscal
2024, primarily driven
by an
increase in
the net
average selling
price of
shell eggs,
primarily conventional
egg prices,
as well
as an
increase in
total
dozens
sold,
primarily
specialty
dozens
sold.
Our
results
were
also
positively
impacted
by
lower
feed
costs
and
our
recent
acquisitions discussed above, partially offset by an increase in the volume and price of outside egg purchases.
Our net
average selling price
per dozen for
the second quarter
of fiscal 2025
was $2.740 compared
to $1.730 in
the prior-year
period. Conventional egg
prices per dozen
were $2.943
compared to $1.458
for the prior-year
period, and specialty
egg prices
per
dozen
were
$2.387
compared
to
$2.277
for
the
prior-year
period.
Egg
prices
in
the
second
quarter
of
fiscal
2025
were
elevated compared to the prior-year
period primarily due to the resurgence
of HPAI
outbreaks, which decreased supply,
among
other
factors.
According
to
the USDA,
the
monthly average
size of
the
layer hen
flock
from
September through
November
(which most closely aligns with our second fiscal quarter) 2024 was approximately 310.7 million hens, which was a decrease of
9.7 million layers, or 3.0%, compared to the same period in the prior year. The daily average price for the Urner Barry southeast
large
index
for
the
second
quarter
of
fiscal
2025
increased
102.1%
from
the
comparable
period
in
the
prior
year.
For
more
information about historical shell egg prices, see Part I Item I of our 2024 Annual Report.